Literature DB >> 24583923

The secret origins and surprising fates of pancreas tumors.

Jennifer M Bailey1, Kathleen E DelGiorno2, Howard C Crawford3.   

Abstract

Pancreatic ductal adenocarcinoma (PDA) is especially deadly due to its recalcitrance to current therapies. One of the unique qualities of PDA that may contribute to this resistance is a striking plasticity of differentiation states starting at tumor formation and continuing throughout tumor progression, including metastasis. Here, we explore the earliest steps of tumor formation and neoplastic progression and how this results in a fascinating cellular heterogeneity that is probably critical for tumor survival and progression. We hypothesize that reinforcing differentiation pathways run awry or targeting morphologically and molecularly distinct tumor stem-like cells may hold promise for future treatments of this deadly disease.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2014        PMID: 24583923      PMCID: PMC4076810          DOI: 10.1093/carcin/bgu056

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  61 in total

Review 1.  Therapeutic advances in pancreatic cancer.

Authors:  Andrew Scott Paulson; Hop S Tran Cao; Margaret A Tempero; Andrew M Lowy
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

2.  EGF receptor is required for KRAS-induced pancreatic tumorigenesis.

Authors:  Christine M Ardito; Barbara M Grüner; Kenneth K Takeuchi; Clara Lubeseder-Martellato; Nicole Teichmann; Pawel K Mazur; Kathleen E Delgiorno; Eileen S Carpenter; Christopher J Halbrook; Jason C Hall; Debjani Pal; Thomas Briel; Alexander Herner; Marija Trajkovic-Arsic; Bence Sipos; Geou-Yarh Liou; Peter Storz; Nicole R Murray; David W Threadgill; Maria Sibilia; M Kay Washington; Carole L Wilson; Roland M Schmid; Elaine W Raines; Howard C Crawford; Jens T Siveke
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

3.  EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma.

Authors:  Carolina Navas; Isabel Hernández-Porras; Alberto J Schuhmacher; Maria Sibilia; Carmen Guerra; Mariano Barbacid
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

Review 4.  Control of cell identity in pancreas development and regeneration.

Authors:  Ben Z Stanger; Matthias Hebrok
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

5.  Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.

Authors:  C A Iacobuzio-Donahue; R E Wilentz; P Argani; C J Yeo; J L Cameron; S E Kern; R H Hruban
Journal:  Am J Surg Pathol       Date:  2000-11       Impact factor: 6.394

6.  Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer.

Authors:  Donghui Li; Eric J Duell; Kai Yu; Harvey A Risch; Sara H Olson; Charles Kooperberg; Brian M Wolpin; Li Jiao; Xiaoqun Dong; Bill Wheeler; Alan A Arslan; H Bas Bueno-de-Mesquita; Charles S Fuchs; Steven Gallinger; Myron Gross; Patricia Hartge; Robert N Hoover; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Andrea LaCroix; Margaret T Mandelson; Gloria Petersen; Wei Zheng; Ilir Agalliu; Demetrius Albanes; Marie-Christine Boutron-Ruault; Paige M Bracci; Julie E Buring; Federico Canzian; Kenneth Chang; Stephen J Chanock; Michelle Cotterchio; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Judith A Hoffman Bolton; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Mazda Jenab; Kay-Tee Khaw; Peter Kraft; Vittorio Krogh; Robert C Kurtz; Robert R McWilliams; Julie B Mendelsohn; Alpa V Patel; Kari G Rabe; Elio Riboli; Xiao-Ou Shu; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Jarmo Virtamo; Kala Visvanathan; Joanne Watters; Herbert Yu; Anne Zeleniuch-Jacquotte; Laufey Amundadottir; Rachael Z Stolzenberg-Solomon
Journal:  Carcinogenesis       Date:  2012-04-20       Impact factor: 4.944

7.  Dclk1 distinguishes between tumor and normal stem cells in the intestine.

Authors:  Yuki Nakanishi; Hiroshi Seno; Ayumi Fukuoka; Taro Ueo; Yuichi Yamaga; Takahisa Maruno; Naoko Nakanishi; Keitaro Kanda; Hideyuki Komekado; Mayumi Kawada; Akihiro Isomura; Kenji Kawada; Yoshiharu Sakai; Motoko Yanagita; Ryoichiro Kageyama; Yoshiya Kawaguchi; Makoto M Taketo; Shin Yonehara; Tsutomu Chiba
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

8.  Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.

Authors:  Janel L Kopp; Guido von Figura; Erin Mayes; Fen-Fen Liu; Claire L Dubois; John P Morris; Fong Cheng Pan; Haruhiko Akiyama; Christopher V E Wright; Kristin Jensen; Matthias Hebrok; Maike Sander
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

9.  EMT and dissemination precede pancreatic tumor formation.

Authors:  Andrew D Rhim; Emily T Mirek; Nicole M Aiello; Anirban Maitra; Jennifer M Bailey; Florencia McAllister; Maximilian Reichert; Gregory L Beatty; Anil K Rustgi; Robert H Vonderheide; Steven D Leach; Ben Z Stanger
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

10.  Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium.

Authors:  François Gerbe; Johan H van Es; Leila Makrini; Bénédicte Brulin; Georg Mellitzer; Sylvie Robine; Béatrice Romagnolo; Noah F Shroyer; Jean-François Bourgaux; Christine Pignodel; Hans Clevers; Philippe Jay
Journal:  J Cell Biol       Date:  2011-03-07       Impact factor: 10.539

View more
  9 in total

Review 1.  Stromal reengineering to treat pancreas cancer.

Authors:  Ingunn M Stromnes; Kathleen E DelGiorno; Philip D Greenberg; Sunil R Hingorani
Journal:  Carcinogenesis       Date:  2014-06-07       Impact factor: 4.944

2.  Paracrine Secretion of Transforming Growth Factor β by Ductal Cells Promotes Acinar-to-Ductal Metaplasia in Cultured Human Exocrine Pancreas Tissues.

Authors:  Naoki Akanuma; Jun Liu; Geou-Yarh Liou; Xue Yin; Kaitlyn R Bejar; Chengyang Liu; Lu-Zhe Sun; Peter Storz; Pei Wang
Journal:  Pancreas       Date:  2017-10       Impact factor: 3.327

3.  The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma.

Authors:  Nathan M Krah; Jean-Paul De La O; Galvin H Swift; Chinh Q Hoang; Spencer G Willet; Fong Chen Pan; Gabriela M Cash; Mary P Bronner; Christopher Ve Wright; Raymond J MacDonald; L Charles Murtaugh
Journal:  Elife       Date:  2015-07-07       Impact factor: 8.140

4.  TGF-β1 promotes acinar to ductal metaplasia of human pancreatic acinar cells.

Authors:  Jun Liu; Naoki Akanuma; Chengyang Liu; Ali Naji; Glenn A Halff; William K Washburn; Luzhe Sun; Pei Wang
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

5.  Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D-driven Pancreatic Tumorigenesis.

Authors:  Nicolas Chuvin; David F Vincent; Roxane M Pommier; Lindsay B Alcaraz; Johann Gout; Cassandre Caligaris; Karam Yacoub; Victoire Cardot; Elodie Roger; Bastien Kaniewski; Sylvie Martel; Celia Cintas; Sophie Goddard-Léon; Amélie Colombe; Julie Valantin; Nicolas Gadot; Emilie Servoz; Jennifer Morton; Isabelle Goddard; Anne Couvelard; Vinciane Rebours; Julie Guillermet; Owen J Sansom; Isabelle Treilleux; Ulrich Valcourt; Stéphanie Sentis; Pierre Dubus; Laurent Bartholin
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-05-31

6.  Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model.

Authors:  Kavita Mallya; Dhanya Haridas; Parthasarathy Seshacharyulu; Ramesh Pothuraju; Wade M Junker; Shiv Ram Krishn; Sakthivel Muniyan; Raghupathy Vengoji; Surinder K Batra; Satyanarayana Rachagani
Journal:  Biol Open       Date:  2020-09-07       Impact factor: 2.422

7.  Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia.

Authors:  Kazumi Ebine; Christina R Chow; Brian T DeCant; Holly Z Hattaway; Paul J Grippo; Krishan Kumar; Hidayatullah G Munshi
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

Review 8.  Pancreatic Cancer and Its Microenvironment-Recent Advances and Current Controversies.

Authors:  Kinga B Stopa; Agnieszka A Kusiak; Mateusz D Szopa; Pawel E Ferdek; Monika A Jakubowska
Journal:  Int J Mol Sci       Date:  2020-05-01       Impact factor: 5.923

9.  Possibility for Transcriptional Targeting of Cancer-Associated Fibroblasts-Limitations and Opportunities.

Authors:  Dina V Antonova; Marina V Zinovyeva; Liya G Kondratyeva; Alexander V Sass; Irina V Alekseenko; Victor V Pleshkan
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.